NEW : European Medicines Agency discourages new Raptiva prescriptions . Raptiva 's product labeling was revised in October to highlight risks . Raptiva is an injection for adults with moderate to severe plaque psoriasis . Raptiva 's product labeling was revised in October to highlight a boxed warning about the risks of life-threatening infections , including PML . ` The FDA has approved the drug, but it remains unclear whether patients will be able to get their medication from pharmacies or doctors.
NEW : European Medicines Agency discourages new Raptiva prescriptions . Raptiva 's product labeling was revised in October to highlight risks . Raptiva is an injection for adults with moderate to severe plaque psoriasis . The FDA has approved the drug, but it remains unclear whether patients will be able to get their medication from pharmacies or doctors.